Importantly, high expression of NME1 was associated to a worse disease-free survival in prostate cancer patients in the TCGA dataset, and high SHMT2 expression in the TCGA and the Glinsky datasets (Figure 6B). Here, SHMT2 is linked to prostate cancer.